| ACE-III | Addenbrooke’s Cognitive Examination III |
| AD | Alzheimer’s disease |
| APP | Amyloid protein precursor |
| BPSDs | behavioural and psychological symptoms of dementia |
| BvFTD | behavioural variant frontotemporal dementia |
| C9orf72 | chromosome 9 open reading frame 72 |
| CDR | Clinical Dementia Rating |
| DLB | Dementia with Lewy Bodies |
| FAQ | Functional Activities Questionnaire |
| FTD | Frontotemporal Dementia |
| FTLD | Frontotemporal Lobar Degeneration |
| M-ACE | Mini-Addenbrooke’s Cognitive Examination |
| MBI | Mild Behavioral Impairment |
| MCI | Mild Cognitive Impairment |
| MMSE | Mini-Mental State Examination |
| MoCA | Montreal Cognitive Assessment |
| MRI | Magnetic Resonance Imaging |
| NPI-Q | Neuropsychiatric Inventory Questionnaire |
| PANSS | Positive And Negative Syndrome Scale |
| PD | Parkinson’s Disease |
| PDD | Parkinson’s Disease Dementia |
| PET | Positron Emission Tomography |
| PPA | Primary Progressive Aphasia |
| PSEN | Presenilin |
| REM | Rapid Eye Movement |
| VaD | Vascular Dementia |